Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Myokardia Inc (MYOK)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Myokardia Inc since year 2005.
Table 2 shows the detailed insider transactions of Myokardia Inc since 2005.
The reporting company's ticker symbol is MYOK. The reporting company's CIK number is 1552451.
The total value of stock buying since 2005 is $35,787,490.
The total value of stock sales since 2005 is $309,558,979.
The total value of stock option exercises since 2005 is $1,271,240.
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2019-09 | 0 | $0 | 5,000 | $265,056 | 0 | $0 |
| 2019-08 | 0 | $0 | 9,565 | $529,348 | 4,565 | $54,551 |
| 2019-07 | 0 | $0 | 5,000 | $253,464 | 0 | $0 |
| 2019-04 | 0 | $0 | 1,324 | $70,569 | 3,750 | $0 |
| 2019-03 | 0 | $0 | 0 | $0 | 1,758 | $21,008 |
| 2019-02 | 0 | $0 | 4,168,899 | $157,000,736 | 0 | $0 |
| 2019-01 | 2,500 | $99,635 | 2,770 | $122,198 | 15,950 | $0 |
| 2018-12 | 0 | $0 | 8,000 | $476,006 | 5,000 | $59,750 |
| 2018-11 | 0 | $0 | 3,978 | $223,757 | 3,000 | $4,521 |
| 2018-10 | 0 | $0 | 3,000 | $174,666 | 3,000 | $4,521 |
| 2018-09 | 0 | $0 | 53,000 | $3,174,790 | 53,000 | $782,021 |
| 2018-08 | 0 | $0 | 3,000 | $171,939 | 3,000 | $4,521 |
| 2018-07 | 0 | $0 | 10,500 | $586,585 | 10,500 | $108,771 |
| 2018-06 | 0 | $0 | 3,000 | $142,974 | 3,000 | $4,521 |
| 2018-05 | 150,000 | $7,350,000 | 4,519 | $217,191 | 2,981 | $4,492 |
| 2018-04 | 0 | $0 | 8,000 | $394,087 | 8,000 | $65,771 |
| 2018-03 | 0 | $0 | 3,164 | $191,559 | 3,164 | $6,010 |
| 2018-02 | 0 | $0 | 15,402 | $898,005 | 13,102 | $58,381 |
| 2018-01 | 0 | $0 | 1,655,652 | $69,636,822 | 8,000 | $12,055 |
| 2017-12 | 0 | $0 | 3,000 | $123,267 | 3,000 | $4,521 |
| 2017-11 | 0 | $0 | 4,300 | $172,920 | 4,300 | $6,480 |
| 2017-10 | 0 | $0 | 79,613 | $3,209,305 | 4,300 | $6,480 |
| 2017-09 | 0 | $0 | 1,629,600 | $69,573,607 | 4,300 | $6,480 |
| 2017-08 | 351,408 | $12,474,984 | 44,300 | $1,358,966 | 4,300 | $6,480 |
| 2017-07 | 0 | $0 | 37,321 | $559,977 | 31,850 | $48,093 |
| 2017-03 | 0 | $0 | 2,079 | $31,185 | 1,200 | $1,812 |
| 2016-10 | 450,000 | $6,750,000 | 0 | $0 | 0 | $0 |
| 2016-04 | 2,279 | $19,371 | 0 | $0 | 0 | $0 |
| 2015-11 | 909,350 | $9,093,500 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-09-11 | Gianakakos Anastasios (President and CEO) | Sale | 1,000 | 55.00 | 55,000 |
| 2019-09-03 | Gianakakos Anastasios (President and CEO) | Sale | 4,000 | 52.51 | 210,056 |
| 2019-08-09 | Lee June (EVP, Chief Development Officer) | Sale | 4,565 | 57.00 | 260,218 |
| 2019-08-09 | Lee June (EVP, Chief Development Officer) | Option Ex | 4,565 | 11.95 | 54,551 |
| 2019-08-08 | Gianakakos Anastasios (President and CEO) | Sale | 1,000 | 55.09 | 55,090 |
| 2019-08-02 | Gianakakos Anastasios (President and CEO) | Sale | 4,000 | 53.51 | 214,040 |
| 2019-07-22 | Gianakakos Anastasios (President and CEO) | Sale | 1,000 | 55.00 | 55,000 |
| 2019-07-05 | Gianakakos Anastasios (President and CEO) | Sale | 4,000 | 49.62 | 198,464 |
| 2019-04-05 | Harris Taylor C. (Chief Financial Officer) | Sale | 1,324 | 53.30 | 70,569 |
| 2019-04-05 | Harris Taylor C. (Chief Financial Officer) | Option Ex | 3,750 | .00 | 0 |
| 2019-03-14 | Lee June (See Remarks) | Option Ex | 1,758 | 11.95 | 21,008 |
| 2019-02-13 | Sanofi (10% Owner) | Sale | 4,168,899 | 37.66 | 157,000,736 |
| 2019-01-07 | Gianakakos Anastasios (President and CEO) | Sale | 2,770 | 44.12 | 122,198 |
| 2019-01-04 | Gianakakos Anastasios (President and CEO) | Buy | 2,500 | 39.85 | 99,635 |
| 2019-01-01 | Lee June (See Remarks) | Option Ex | 2,750 | .00 | 0 |
| 2019-01-01 | Semigran Marc (Chief Medical Officer) | Option Ex | 1,325 | .00 | 0 |
| 2019-01-01 | Lambing Joseph (See Remarks) | Option Ex | 875 | .00 | 0 |
| 2019-01-01 | Bauer Jake (Chief Business Officer) | Option Ex | 1,425 | .00 | 0 |
| 2019-01-01 | Gianakakos Anastasios (President and CEO) | Option Ex | 7,650 | .00 | 0 |
| 2019-01-01 | Mcdowell Robert Scott (Chief Scientific Officer) | Option Ex | 1,925 | .00 | 0 |
| 2018-12-12 | Gianakakos Anastasios (President and CEO) | Sale | 3,000 | 55.68 | 167,046 |
| 2018-12-03 | Lee June (See Remarks) | Sale | 5,000 | 61.79 | 308,960 |
| 2018-12-03 | Lee June (See Remarks) | Option Ex | 5,000 | 11.95 | 59,750 |
| 2018-11-05 | Gianakakos Anastasios (President and CEO) | Sale | 3,000 | 56.51 | 169,527 |
| 2018-11-05 | Gianakakos Anastasios (President and CEO) | Option Ex | 3,000 | 1.51 | 4,521 |
| 2018-11-02 | Bauer Jake (Chief Business Officer) | Sale | 978 | 55.45 | 54,230 |
| 2018-10-04 | Gianakakos Anastasios (President and CEO) | Sale | 3,000 | 58.22 | 174,666 |
| 2018-10-04 | Gianakakos Anastasios (President and CEO) | Option Ex | 3,000 | 1.51 | 4,521 |
| 2018-09-21 | Lee June (See Remarks) | Sale | 5,000 | 63.41 | 317,025 |
| 2018-09-21 | Lee June (See Remarks) | Option Ex | 5,000 | 11.95 | 59,750 |
| 2018-09-05 | Semigran Marc (Chief Medical Officer) | Sale | 3,600 | 60.00 | 216,000 |
| 2018-09-05 | Semigran Marc (Chief Medical Officer) | Option Ex | 3,600 | 15.95 | 57,420 |
| 2018-09-04 | Semigran Marc (Chief Medical Officer) | Sale | 41,400 | 59.49 | 2,463,010 |
| 2018-09-04 | Semigran Marc (Chief Medical Officer) | Option Ex | 41,400 | 15.95 | 660,330 |
| 2018-09-04 | Gianakakos Anastasios (President and CEO) | Sale | 3,000 | 59.59 | 178,755 |
| 2018-09-04 | Gianakakos Anastasios (President and CEO) | Option Ex | 3,000 | 1.51 | 4,521 |
| 2018-08-06 | Gianakakos Anastasios (President and CEO) | Sale | 3,000 | 57.31 | 171,939 |
| 2018-08-06 | Gianakakos Anastasios (President and CEO) | Option Ex | 3,000 | 1.51 | 4,521 |
| 2018-07-23 | Bauer Jake (Chief Business Officer) | Sale | 7,500 | 56.94 | 427,012 |
| 2018-07-23 | Bauer Jake (Chief Business Officer) | Option Ex | 7,500 | 13.90 | 104,250 |
| 2018-07-05 | Gianakakos Anastasios (President and CEO) | Sale | 3,000 | 53.19 | 159,573 |
| 2018-07-05 | Gianakakos Anastasios (President and CEO) | Option Ex | 3,000 | 1.51 | 4,521 |
| 2018-06-04 | Gianakakos Anastasios (President and CEO) | Sale | 3,000 | 47.66 | 142,974 |
| 2018-06-04 | Gianakakos Anastasios (President and CEO) | Option Ex | 3,000 | 1.51 | 4,521 |
| 2018-05-25 | Sanofi (10% Owner) | Buy | 150,000 | 49.00 | 7,350,000 |
| 2018-05-04 | Gianakakos Anastasios (President and CEO) | Sale | 3,000 | 47.61 | 142,836 |
| 2018-05-04 | Gianakakos Anastasios (President and CEO) | Option Ex | 2,981 | 1.51 | 4,492 |
| 2018-05-03 | Bauer Jake (Chief Business Officer) | Sale | 1,519 | 48.95 | 74,355 |
| 2018-04-11 | Bauer Jake (See Remarks) | Sale | 5,000 | 50.00 | 250,000 |
| 2018-04-11 | Bauer Jake (See Remarks) | Option Ex | 5,000 | 12.25 | 61,250 |
| 2018-04-04 | Gianakakos Anastasios (President and CEO) | Sale | 3,000 | 48.03 | 144,087 |
| 2018-04-04 | Gianakakos Anastasios (President and CEO) | Option Ex | 3,000 | 1.51 | 4,521 |
| 2018-03-26 | Bauer Jake (See Remarks) | Sale | 164 | 50.95 | 8,355 |
| 2018-03-26 | Bauer Jake (See Remarks) | Option Ex | 164 | 9.08 | 1,489 |
| 2018-03-05 | Gianakakos Anastasios (President and CEO) | Sale | 3,000 | 61.07 | 183,204 |
| 2018-03-05 | Gianakakos Anastasios (President and CEO) | Option Ex | 3,000 | 1.51 | 4,521 |
| 2018-02-26 | Lambing Joseph (See Remarks) | Sale | 2,300 | 60.00 | 138,000 |
| 2018-02-26 | Bauer Jake (See Remarks) | Sale | 5,102 | 60.00 | 306,120 |
| 2018-02-26 | Bauer Jake (See Remarks) | Option Ex | 5,102 | 9.08 | 46,326 |
| 2018-02-26 | Gianakakos Anastasios (President and CEO) | Sale | 5,000 | 60.00 | 300,000 |
| 2018-02-26 | Gianakakos Anastasios (President and CEO) | Option Ex | 5,000 | 1.51 | 7,534 |
| 2018-02-05 | Gianakakos Anastasios (President and CEO) | Sale | 3,000 | 51.30 | 153,885 |
| 2018-02-05 | Gianakakos Anastasios (President and CEO) | Option Ex | 3,000 | 1.51 | 4,521 |
| 2018-01-12 | Lambing Joseph (See Remarks) | Sale | 5,000 | 50.00 | 250,000 |
| 2018-01-12 | Gianakakos Anastasios (President and CEO) | Sale | 5,000 | 50.00 | 250,000 |
| 2018-01-12 | Gianakakos Anastasios (President and CEO) | Option Ex | 5,000 | 1.51 | 7,534 |
| 2018-01-09 | Bauer Jake (See Remarks) | Sale | 5,000 | 45.00 | 225,000 |
| 2018-01-04 | Gianakakos Anastasios (President and CEO) | Sale | 3,000 | 41.70 | 125,103 |
| 2018-01-04 | Gianakakos Anastasios (President and CEO) | Option Ex | 3,000 | 1.51 | 4,521 |
| 2018-01-03 | Starr Kevin P (Director) | Sale | 816,326 | 42.00 | 34,285,692 |
| 2018-01-03 | Tepper Robert I (10% Owner) | Sale | 816,326 | 42.00 | 34,285,692 |
| 2018-01-02 | Bauer Jake (See Remarks) | Sale | 5,000 | 43.07 | 215,335 |
| 2017-12-21 | Gianakakos Anastasios (President and CEO) | Sale | 3,000 | 41.09 | 123,267 |
| 2017-12-21 | Gianakakos Anastasios (President and CEO) | Option Ex | 3,000 | 1.51 | 4,521 |
| 2017-11-06 | Gianakakos Anastasios (President and CEO) | Sale | 4,300 | 40.21 | 172,920 |
| 2017-11-06 | Gianakakos Anastasios (President and CEO) | Option Ex | 4,300 | 1.51 | 6,480 |
| 2017-10-04 | Gianakakos Anastasios (President and CEO) | Sale | 4,300 | 40.86 | 175,698 |
| 2017-10-04 | Gianakakos Anastasios (President and CEO) | Option Ex | 4,300 | 1.51 | 6,480 |
| 2017-10-03 | Starr Kevin P (Director) | Sale | 75,313 | 40.28 | 3,033,607 |
| 2017-09-26 | Starr Kevin P (Director) | Sale | 400,000 | 43.00 | 17,200,000 |
| 2017-09-26 | Tepper Robert I (10% Owner) | Sale | 400,000 | 43.00 | 17,200,000 |
| 2017-09-25 | Starr Kevin P (Director) | Sale | 201,400 | 43.00 | 8,660,200 |
| 2017-09-25 | Tepper Robert I (10% Owner) | Sale | 201,400 | 43.00 | 8,660,200 |
| 2017-09-11 | Tepper Robert I (10% Owner) | Sale | 20,000 | 44.25 | 885,080 |
| 2017-09-08 | Starr Kevin P (Director) | Sale | 201,250 | 41.69 | 8,390,917 |
| 2017-09-08 | Tepper Robert I (10% Owner) | Sale | 201,250 | 41.69 | 8,390,917 |
| 2017-09-05 | Gianakakos Anastasios (President and CEO) | Sale | 4,300 | 43.32 | 186,293 |
| 2017-09-05 | Gianakakos Anastasios (President and CEO) | Option Ex | 4,300 | 1.51 | 6,480 |
| 2017-08-22 | Lambing Joseph (See Remarks) | Sale | 5,000 | 45.00 | 225,000 |
| 2017-08-15 | Lambing Joseph (See Remarks) | Sale | 5,000 | 40.00 | 200,000 |
| 2017-08-14 | Yarno Wendy L (Director) | Buy | 1,408 | 35.50 | 49,984 |
| 2017-08-14 | Sanofi (10% Owner) | Buy | 350,000 | 35.50 | 12,425,000 |
| 2017-08-08 | Lambing Joseph (See Remarks) | Sale | 5,000 | 35.00 | 175,000 |
| 2017-08-07 | Lambing Joseph (See Remarks) | Sale | 10,000 | 27.50 | 275,000 |
| 2017-08-07 | Bauer Jake (See Remarks) | Sale | 15,000 | 27.50 | 412,500 |
| 2017-08-04 | Gianakakos Anastasios (President and CEO) | Sale | 4,300 | 16.62 | 71,466 |
| 2017-08-04 | Gianakakos Anastasios (President and CEO) | Option Ex | 4,300 | 1.51 | 6,480 |
| 2017-07-25 | Bauer Jake (See Remarks) | Sale | 4,333 | 15.02 | 65,059 |
| 2017-07-25 | Gianakakos Anastasios (President and CEO) | Sale | 32,988 | 15.00 | 494,918 |
| 2017-07-25 | Gianakakos Anastasios (President and CEO) | Option Ex | 31,850 | 1.51 | 48,093 |
| 2017-03-20 | Bauer Jake (See Remarks) | Sale | 667 | 15.00 | 10,005 |
| 2017-03-20 | Gianakakos Anastasios (President and CEO) | Sale | 1,412 | 15.00 | 21,180 |
| 2017-03-20 | Gianakakos Anastasios (President and CEO) | Option Ex | 1,200 | 1.51 | 1,812 |
| 2016-10-03 | Sanofi (10% Owner) | Buy | 450,000 | 15.00 | 6,750,000 |
| 2016-04-29 | Gianakakos Anastasios (President and CEO) | Buy | 2,279 | 8.50 | 19,371 |
| 2015-11-03 | Fox Jonathan C (Chief Medical Officer) | Buy | 3,000 | 10.00 | 30,000 |
| 2015-11-03 | Gianakakos Anastasios (President and CEO) | Buy | 1,350 | 10.00 | 13,500 |
| 2015-11-03 | Perry Mark L (Director) | Buy | 5,000 | 10.00 | 50,000 |
| 2015-11-03 | Sanofi (10% Owner) | Buy | 900,000 | 10.00 | 9,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of MYOK listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Myokardia Inc (symbol MYOK, CIK number 1552451) see the Securities and Exchange Commission (SEC) website.